Clinical Trial Update: The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating a medical grade honey formulation (L-Mesitran) for symptoms of recurrent vulvovaginal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis of Vagina
• Vulvovaginal Candidiasis

Drugs mentioned

• L-Mesitran

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina | Phase 3 | Status: RECRUITING